Vaccines and Diagnostics Trials
疫苗和诊断试验
基本信息
- 批准号:7632160
- 负责人:
- 金额:$ 21.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:ClinicalClinical ResearchClinical TrialsCollaborationsConduct Clinical TrialsConsentConsent FormsCore FacilityData AnalysesData CollectionDiagnosticDiagnostic TrialDisease OutbreaksDocumentationElementsEmerging Communicable DiseasesEpidemiologic StudiesEvaluationInfectious Diseases ResearchInvestigationManuscriptsMissionPersonal SatisfactionPhasePhase I Clinical TrialsPhase II Clinical TrialsPopulationPopulation StudyProceduresProtocols documentationReportingResearch PersonnelResearch ProposalsResourcesTranslational ResearchVaccine ResearchVaccinesValidationWorkWritingbasebiodefenseexperienceinstrumentnovel diagnosticspre-clinicalresearch clinical testingresearch studyvalidation studies
项目摘要
An essential element of a Regional Center of Excellence (RCE) for Biodefense and Emerging
Infectious Disease Research proposal is the capacity to coordinate and conduct phase I and il
clinical tirals as well as to conduct relevant popluation based epidemiologic studies and diagnostic
validation studies. The UCLA Center for Vaccine Research has the expertise, experience, staffing,
resources and facilities to conduct such clinical evaluations that will contribute to the RCE's mission
for translational research. The specific aims for our core proposal include: 1) collaborate with RCE
investigators to evaluate pre-clinical evaluations and develop clinical research plans, 2) develop
and write protocols for phase I and phase II clinical evaiuatjons and epidemiologic studies, 3)
develop relevant consent forms, regulatory documents, data collection instruments and procedures,
4) identify appropriate study populations, 5) conduct clinical trials, epidemiologic studies, and
validation studies for new diagnostics, and 6) perform data collection and data analyses and
prepare clinical reports and manuscripts.
生物防御和新兴领域卓越区域中心(RCE)的重要组成部分
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel I. Ward其他文献
Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.
流感嗜血杆菌 B 型破伤风类毒素结合疫苗与白喉-破伤风-无细胞百日咳-乙型肝炎联合疫苗混合时的免疫原性。
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:0
- 作者:
David P. Greenberg;V. Wong;S. Partridge;Swei;Jennie Jing;B. Howe;Joel I. Ward - 通讯作者:
Joel I. Ward
Tricuspid valve endocarditis due to Staphylococcus aureus. Correlation of two-dimensional echocardiography with clinical outcome.
金黄色葡萄球菌引起的三尖瓣心内膜炎。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:9.6
- 作者:
Arnold S. Bayer;Arnold S. Bayer;Ingrid K. Blomquist;Ingrid K. Blomquist;Erlaine Bello;Erlaine Bello;C. Chiu;C. Chiu;Joel I. Ward;Joel I. Ward;L. Ginzton;L. Ginzton - 通讯作者:
L. Ginzton
Tricuspid Valve Endocarditis due to <em>Staphylococcus aureus</em>: Correlation of Two-Dimensional Echocardiography with Clinical Outcome
- DOI:
10.1378/chest.93.2.247 - 发表时间:
1988-02-01 - 期刊:
- 影响因子:
- 作者:
Arnold S. Bayer;Ingrid K. Blomquist;Erlaine Bello;Chung-Yin Chiu;Joel I. Ward;Leonard E. Ginzton - 通讯作者:
Leonard E. Ginzton
Paralytic syndromes in children: epidemiology and relationship to vaccination.
儿童麻痹综合征:流行病学及其与疫苗接种的关系。
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:3.8
- 作者:
K. Zangwill;Sylvia H. Yeh;Emily J. Wong;S. M. Marcy;E. Eriksen;Kenneth R. Huff;Martin Lee;Edwin Lewis;Steven B. Black;Joel I. Ward - 通讯作者:
Joel I. Ward
Genetic factors in <em>Haemophilus influenzae</em> type b disease susceptibility and antibody acquisition
- DOI:
10.1016/s0022-3476(87)80159-2 - 发表时间:
1987-02-01 - 期刊:
- 影响因子:
- 作者:
Gloria M. Petersen;Diana R. Silimperi;Jerome I. Rotter;Paul I. Terasaki;Moses S. Schanfield;Min S. Park;Joel I. Ward - 通讯作者:
Joel I. Ward
Joel I. Ward的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel I. Ward', 18)}}的其他基金
A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLACT
评估预防措施的双盲、随机、对照 III 期研究
- 批准号:
8174475 - 财政年份:2009
- 资助金额:
$ 21.85万 - 项目类别:
A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLACT
评估预防措施的双盲、随机、对照 III 期研究
- 批准号:
7952222 - 财政年份:2008
- 资助金额:
$ 21.85万 - 项目类别:
A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLACT
评估预防措施的双盲、随机、对照 III 期研究
- 批准号:
7606167 - 财政年份:2007
- 资助金额:
$ 21.85万 - 项目类别:
A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLACT
评估预防措施的双盲、随机、对照 III 期研究
- 批准号:
7376064 - 财政年份:2005
- 资助金额:
$ 21.85万 - 项目类别:
PILOT STUDY TO OPTIMIZE AND STANDARDIZE UMBILICAL CORD BLOOD COLLECTION AND T
优化和标准化脐带血采集和 T 的试点研究
- 批准号:
7376111 - 财政年份:2005
- 资助金额:
$ 21.85万 - 项目类别:
PILOT STUDY TO OPTIMIZE AND STANDARDIZE UMBILICAL CORD BLOOD COLLECTION AND T
优化和标准化脐带血采集和 T 的试点研究
- 批准号:
7206414 - 财政年份:2004
- 资助金额:
$ 21.85万 - 项目类别:
A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE III STUDY TO ASSESS THE PROPHYLACT
评估预防措施的双盲、随机、对照 III 期研究
- 批准号:
7206383 - 财政年份:2004
- 资助金额:
$ 21.85万 - 项目类别:
Multicenter, Double-Blind, Randomized, Dose-Response Stu
多中心、双盲、随机、剂量反应研究
- 批准号:
7042133 - 财政年份:2003
- 资助金额:
$ 21.85万 - 项目类别:
A Double-Blind, Randomized, Controlled Phase III Study to Assess the Prophylact.
评估预防剂的双盲、随机、对照 III 期研究。
- 批准号:
7042132 - 财政年份:2003
- 资助金额:
$ 21.85万 - 项目类别:
相似海外基金
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 21.85万 - 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
- 批准号:
10754981 - 财政年份:2023
- 资助金额:
$ 21.85万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10617997 - 财政年份:2022
- 资助金额:
$ 21.85万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10538151 - 财政年份:2021
- 资助金额:
$ 21.85万 - 项目类别:
Admin. Supp. for NCI P30 Cancer Center Grants to Facilitate the Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites
行政。
- 批准号:
10442122 - 财政年份:2021
- 资助金额:
$ 21.85万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10624966 - 财政年份:2021
- 资助金额:
$ 21.85万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10515803 - 财政年份:2021
- 资助金额:
$ 21.85万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10258627 - 财政年份:2021
- 资助金额:
$ 21.85万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10581505 - 财政年份:2019
- 资助金额:
$ 21.85万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10379715 - 财政年份:2019
- 资助金额:
$ 21.85万 - 项目类别:














{{item.name}}会员




